Comprehensive review aims to clarify growing public concern around Ozempic®, Wegovy®, and Mounjaro® TAMPA, Fla., Feb. 10, 2026 /PRNewswire/ -- With the rapid rise in use of GLP-1 receptor agonist medications such as Ozempic®, Wegovy®, and Mounjaro® for diabetes and weight loss, public concern has grown over a possible link to thyroid cancer. A newly released white paper from the Clayman Thyroid Center offers a comprehensive review of the scientific evidence and concludes that the best available

Contract awarded for products that bring improvement to healthcare industry DOTHAN, Ala., Feb. 10, 2026 /PRNewswire/ -- ORCA Products announced its ORCA Dental Emergency Pain Kit has received an Innovative Technology contract from Vizient® the nation's largest provider-driven healthcare performance improvement company. The contract was awarded based on review of ORCA Dental Emergency Pain Kit from hospital experts who serve on one of Vizient's client-led councils, and it signifies to Vizient cli

First Alleged U.S. Death from Defective Glucose Monitors Prompts Legal Action—7 Deaths Reported Globally, 3 Million Devices Recalled ONTARIO, Calif., Feb. 10, 2026 /PRNewswire/ -- McCune Law Group has filed a wrongful death lawsuit against Abbott Diabetes Care Inc. and Abbott Laboratories over alleged defects in the FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems. According to the complaint filed in Alameda County Superior Court on February 2, 2026, these defe

Veteran laboratory operations leader brings deep expertise scaling high-complexity CLIA/CAP environments and multiomic platforms to support FYR's EV-Omics growth across neuroscience and oncology MISSOULA, Mont., Feb. 10, 2026 /PRNewswire/ -- FYR Bio ("FYR"), a biotechnology company leveraging extracellular vesicles (EVs) to deliver AI-enabled multiomic insights from a peripheral blood sample, today announced the appointment of Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as Chief Operating Office

MONTREAL, Feb. 10, 2026 /PRNewswire/ - On February 3rd, 2026, the Executive Board of the World Health Organization (WHO), in a landmark decision, approved a Member-State led resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, which will now be presented at the 79th World Health Assembly in May 2026 for final adoption. The World Federation of Hemophilia (WFH)—as a non-state actor in official relations with the WHO­—has been advocating and

Enhanced EHR-workflow-integrated communications enable prescribers to act on lower-cost therapeutic alternatives, while reinforcing Scripta's proven member-driven savings model BOSTON, Feb. 10, 2026 /PRNewswire/ -- Scripta Insights, the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans, and their members to prescription savings, has strengthened its provider engagement capabilities through enhanced, secure EHR-workflow-integrated electronic f

HONG KONG, Feb. 10, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced that its wholly owned subsidiary, DZR Tech Limited ("DZR"), entered into a definitive share purchase agreement on February 5, 2026 (the "Agreement") with the sole shareholder of Daren Business Technol

New integrated design, enhanced connectivity, and streamlined hardware mark a major evolution in Freespira's platform, significantly improving overall user experience KIRKLAND, Wash., Feb. 10, 2026 /PRNewswire/ -- Freespira, developer of the first FDA-cleared at-home treatment for anxiety disorders, including panic disorder and post-traumatic stress disorder (PTSD), today announced the launch of Freespira Sensor Technology v5 (FST5), its fifth-generation device that, for the first time, combines

RespiRx ™ achieves cigarette-comparable nicotine delivery with favorable safety profile, marking first major advancement in smoking cessation in decades IRVINE, Calif., Feb. 10, 2026 /PRNewswire/ -- Qnovia, Inc., a pharmaceutical and medtech company revolutionizing inhaled therapeutics, today announced positive results from its Phase 1 clinical trial evaluating the safety and efficacy of RespiRx™, a handheld inhalable nicotine replacement therapy (NRT). With this milestone, Qnovia's ultraportab

WASHINGTON, Feb. 10, 2026 /PRNewswire/ -- President Donald J. Trump has announced the launch of TrumpRx.gov, a new federal pathway that allows patients to obtain high-cost prescription medicines directly from manufacturers, bypassing Pharmacy Benefit Managers (PBMs) whose intermediary role has been a primary driver of inflated drug prices in the United States. The initiative adopts a policy framework formally submitted by Professor Sarfaraz Niazi, Ph.D., in response to a direct request from t